A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
Clinical trial NCT05931757 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05931757
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-06-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.